Current Illinois CancerCare Clinical Trals

Sarcoma


A092107 (JIT)

A Randomized Phase 2 Trial With a Safety Lead-In to Evaluate Palbociclib Versus Palbociclib and Cemiplimab for the Treatment of Advanced Dedifferentiated Liposarcoma


Search Again